Unilab Chemicals And Pharmaceuticals Private Limited, a active private limited company, was established on 31 March 1978 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110MH1978PTC020256. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Dipak Kantilal Vora (Director), Smita Dipak Vora (Director), Rahul Dipak Vora (Director). Past directors included Sharmishta Vora Shantilal, Rahul Dipak Vora. It holds ₹15.56 Cr open charges and ₹6.30 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-12, 4Th Floor, Pinnacle Business Park, Mahakali Caves Road, Shanti Nagar, Andhe, Ri East, Mumbai, Maharashtra, 400093.
U24110MH1978PTC020256
020256
31 March 1978
₹1.00 Cr
₹2.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Unilab Chemicals And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dipak Kantilal Vora | Director | 10 Jun 1994 | Current |
| Smita Dipak Vora | Director | 01 Mar 2001 | Current |
| Rahul Dipak Vora | Director | 12 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jul 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unilab Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.47% decrease. The company also saw a substantial fall in profitability, with a 12.88% decrease in profit. The company's net worth moved up by a moderate rise of 8.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Unilab Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹155,581,000.00
₹63,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 2022 | Sidbi | ₹5.00 Cr | Open |
| 24 Jul 2006 | Idbi Bank Limited | ₹5.84 Cr | Open |
| 03 Dec 2002 | Idbi Bank Limited | ₹4.72 Cr | Open |
| 28 Jan 2021 | Citi Bank N.A. | ₹4.00 Cr | Satisfied |
| 18 Jun 2020 | Sidbi | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Unilab Chemicals And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unilab Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilab Chemicals And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Unilab Chemicals And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Unilab Chemicals And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge registered on 18 Jun 2020 via Charge ID 100347257 with Sidbi was fully satisfied on 15 Feb 2024. was documented.
A charge registered on 28 Jan 2021 via Charge ID 100420685 with Citi Bank N.A. was fully satisfied on 14 Feb 2024. was recorded as a recent event.
The activity A charge registered on 29 Sep 2017 via Charge ID 100188388 with Citi Bank N.A. was fully satisfied on 14 Feb 2024. was completed.
Progress on A charge with Sidbi amounted to Rs. 5.00 Cr with Charge ID 100607022 was registered on 17 Aug 2022. was documented.
The CIN of Unilab Chemicals And Pharmaceuticals Private Limited is U24110MH1978PTC020256.
Unilab Chemicals And Pharmaceuticals Private Limited is headquartered at F-12, 4Th Floor, Pinnacle Business Park, Mahakali Caves Road, Shanti Nagar, Andhe, Ri East, Mumbai, Maharashtra, 400093.
Unilab Chemicals And Pharmaceuticals Private Limited was incorporated on 31 March 1978.
The current directors of Unilab Chemicals And Pharmaceuticals Private Limited are
The primary industry of Unilab Chemicals And Pharmaceuticals Private Limited is Manufacturing.
Unilab Chemicals And Pharmaceuticals Private Limited is unlisted.
The authorized capital of Unilab Chemicals And Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹2.50 M.
The compliance status of Unilab Chemicals And Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX